- Tracebility requirements in Pharma vs Medical Devices - Nonconformance issue
- SUPAC (Scale Up and Post Approval Changes) guidelines for pharmaceuticals
- Comparison of EU and US GMPs - Differences applying CFR211 or the EU GMPs
- IS there such a thing as FDA "Good Distribution Practices"
- ISO 15378:2006, Primary packaging materials for medicinal products
- Auditing Pharmaceutical Toll Manufacturers
- Key Performance Indicators in a pharmaceutical company
- Pharmaceutical Company Quality Manual
- Permanent Inspection Readiness for a pharma manufacturing firm
- Transitioning from ISO 9001 to CFR - Recently transferred to a Pharma company
- ISO 13485 Similarities to 21 CFR Part 210/211 (Pharmaceuticals) for Quality systems
- The most current version or draft of the Q10 - Pharmaceutical Quality Systems
- What is the link between FDA and US Pharmacopeia?
- Questions about cGMP in a pharmaceutical company in China
- FDA Compliance - CMC quality and regulatory issues & cGMP - 21CFR parts 210 and 211
- GIVE (Generic Initiative for Value and Efficiency) Launched by the FDA (US)
- Liability for Packaged Drug products Sold Indirectly in the International Market.
- Part 11 Requirements - Medical Devices vs. Pharmaceuticals
- Tabular Gap Analysis of the EU (volume 4) and US (210/211) cGMP Regulations
- Can a prescription type material be used as a predicate for an OTC material?
- Calculation for Similarity and Differences in dissolution profile (F1&F2 Values)
- 21 CFR parts 210 and 211 - CURRENT GMP FOR FINISHED PHARMACEUTICALS
- 21 CFR 201.66 Format And Content Requirements For OTC Drug Facts Labeling
- USP (United States Pharmacopeia’s) Compliant Packaging Regulations & Process
- Rework vs. Reprocess - Definitions - Pharmaceuticals
- Drug product physical properties stability studies - which properties to test?
- FDA - "Net Quantity of Contents" - Manufacturing filling process
- Sterility (bacteriostasis/fungistasis) Testing by Membrane Filtration validation
- Is Medical Grade Gas always a drug?
- Any one know about FDA's GMP, 21 CFR Part 111
- Change Control for FDA industry - Drug Manufacturer
- Facility qualification - API (Active Pharmaceutical Ingredient) industry
- ANDA (Abbreviated New Drug Application) Filing - Ophthalmic Solution
- Drug Registration in European Union - European Medicines Agency (EMEA)
- Barcode Format Question - Variable vs. Fixed Segment Length
- Clinical trials - Generic "parent" procedure vs. study-specific "child" versions
- Relationship between Blend Uniformity and Content Uniformity
- Roles and Responsibilities for new Documentation and Compliance team
- Guideline for streamlined batch record review process - cGMP compliance - Needed
- Environment Monitoring programme for pharmaceutical industry
- CDSCO Guidelines for Port Officers on Imp and Export of Drugs & Cosmetics
- Teva recalls drug following Jackson death probe
- Facts and Myths about Generic Drugs
- GMP question - New pharma/drug manufacturing facility certification timeline/sequence
- Compatibilty between two substances (Amidopyrin and Methampyron)
- FDA approves Influenza A (H1N1) 2009 vaccines
- Deviation Record Example for a Pharma Company
- ISO 13485 and ISO 14971 - Medical Devices and Related Forums





